Research Alliance II, the second blank check company formed by RA Capital targeting the biotech industry, raised $130 million by offering 13 million shares at $10. The company did not offer units with warrants attached. It may raise an additional $30...read more
Research Alliance II, the second blank check company formed by RA Capital targeting the biotech industry, filed on Tuesday with the SEC to raise up to $130 million in an initial public offering. The Las Vegas, NV-based company plans to raise $130 million...read more
RA Capital's SPAC Research Alliance II prices $130 million IPO
Research Alliance II, the second blank check company formed by RA Capital targeting the biotech industry, raised $130 million by offering 13 million shares at $10. The company did not offer units with warrants attached. It may raise an additional $30...read more
RA Capital's SPAC Research Alliance II files for a $130 million IPO
Research Alliance II, the second blank check company formed by RA Capital targeting the biotech industry, filed on Tuesday with the SEC to raise up to $130 million in an initial public offering. The Las Vegas, NV-based company plans to raise $130 million...read more